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http:WHAT DOES THIS STUDY ADD TO THE EXISTING LITERATURE AND HOW WILL IT INFLUENCE FUTURE CLINICAL
PRACTICE?
This study adds prognostic information for a well-deﬁned population of people with a ﬁrst amputation at or
proximal to a transtibial level, due to a vascular or infection related cause. Mortality rates were 22% at 30 days,
44% at 1 year and 77% at 5 years. Median survival was 20.3 months. The importance of deﬁning the population
when reporting and using mortality rates in people with amputation is discussed.Objective: To determine mortality rates after a ﬁrst lower limb amputation and explore the rates for different
subpopulations.
Methods: Retrospective cohort study of all people who underwent a ﬁrst amputation at or proximal to transtibial
level, in an area of 1.7 million people. Analysis with Kaplan-Meier curves and Log Rank tests for univariate
associations of psycho-social and health variables. Logistic regression for odds of death at 30-days, 1-year and 5-
years.
Results: 299 people were included. Median time to death was 20.3 months (95%CI: 13.1; 27.5). 30-day
mortality ¼ 22%; odds of death 2.3 times higher in people with history of cerebrovascular disease (95%CI: 1.2;
4.7, P ¼ 0.016). 1 year mortality ¼ 44%; odds of death 3.5 times higher for people with renal disease (95%CI: 1.8;
7.0, P < 0.001). 5-years mortality ¼ 77%; odds of death 5.4 times higher for people with renal disease (95%CI:
1.8; 16.0,P ¼ 0.003). Variation in mortality rates was most apparent in different age groups; people 75e84 years
having better short term outcomes than those younger and older.
Conclusions:Mortality rates demonstrated the frailty of this population, with almost one quarter of people dying
within 30-days, and almost half at 1 year. People with cerebrovascular had higher odds of death at 30 days, and
those with renal disease and 1 and 5 years, respectively.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Mortality rates after lower limb amputation (LLA) are
notoriously high. This is attributed to the population being
comprised of old and medically frail people at the time of
undergoing a major surgical procedure. Older age, proximal
amputation levels and multi-morbidity, particularly renal
disease, are all associated with a higher rate of mortality
after amputation.1e4 Despite this acceptance of a high risk
of mortality after LLA, reported rates are wide-ranging.
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//dx.doi.org/10.1016/j.ejvs.2013.03.024criteria. As an example, 1 year after amputation, mortality
rates as low as 22% have been reported in a population that
included partial foot amputation.5 Focusing only on trans-
tibial and more proximal levels, mortality rates can reach as
high as 52% at 1 year.6,7 Additional factors, such as the
inclusion of only people undergoing their ﬁrst amputation
or also subsequent amputations, different causes of
amputation, or the source used for death registration can
also inﬂuence these rates. Unfortunately, this information is
not always clear, limiting our ability to make valid
comparisons across studies.
With treatment options for wound care and at-risk limbs
continually changing8 the mortality risk and proﬁle of
people with amputation is also likely to differ. From the
perspective of planning and providing rehabilitation
services, the characteristics of the population surviving to
different time points can provide valuable insight. Under-
standing the timing and reasons for mortality after ampu-
tation in different subgroups may also help to identify
speciﬁc risk factors and open new ideas for pre- and post-
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30-day, 1-year, and 5-year mortality rates after a ﬁrst
amputation, at or proximal to transtibial level in our region.
Differences by population characteristics including level of
amputation, age groups and diabetes status are explored,
along with major co-morbidities, medical and surgical
history, and admission and discharge settings.
MATERIALS AND METHODS
The medical ethics committee of the University Medical
Centre Groningen ruled that a formal approval was not
required for this retrospective medical record review.
Setting and population
The study was conducted in all 14 hospitals of the three
Northern provinces of the Netherlands: Groningen,
Friesland and Drenthe. This region had a total population
of approximately 1.7 million people in the inclusion
period, with around 14% aged over 65 years in the study
period.9
Each hospital compiled a list of all people who had an
amputation at a transtibial level or proximal, in 2003 or
2004. Changes to recording of data were instigated in
2005 which affected the reliability of data in the years
following. With this in mind, and to allow for a sufﬁcient
follow up time, the period 1 January 2003 to 31 December
2004 was chosen. The incidence of amputation in this
setting was reported previously at 8.8 per 100,00 person-
years.10
Medical records for all cases were reviewed between
August 2010 and June 2011. People who had undergone
amputation at transtibial level or proximal, on either limb,
before 1 January 2003 were excluded. People with
a previous amputation distal to, and including, ankle
disarticulation were included. Where multiple amputations
occurred within the study period (either re-amputation to
a higher level or a bilateral amputation), the date of the
ﬁrst amputation was used to calculate time to death.
Amputations that were the result of trauma, cancer,
complex regional pain syndrome or congenital causes were
excluded, thus leaving a cohort with amputation resulting
from vascular disease, infection and/or diabetes. Amputa-
tion date, side and level (unilateral TT, unilateral proximal
(KD or TF), or bilateral) were recorded for the study period,
as well as any amputations performed in the years
following.
Variables
The primary dependent variable was time to death. The
date of death was recorded from hospital records, or
general practitioners were contacted for an updated status
(alive or date of death) in August 2011.
Characteristics of the population included as indepen-
dent variables were: age; sex; marital status (dichotomised
as partner or alone (includes single, widowed, divorced));
living situation prior to admission for amputation (home,
nursing home, other); discharge destination (home,inpatient rehabilitation centre, nursing home, supported
residential home, other hospital, or died before discharge);
and smoking history (ever, never). Medical diagnoses were
based on a list of items from the Charlson Comorbidity
Index, with the most frequent diagnoses presented under
combined groups of cardiac disease, cerebrovascular
disease, lung disease, renal disease, diabetes (see Appendix 1).
Where a diagnosis was unclear, details (including medica-
tions) were noted and discussed with a medical specialist
for clariﬁcation. In addition, it was noted if a patient had
diabetes type I or type II and whether they were receiving
dialysis. Surgical history was recorded and included
previous peripheral vascular procedures (e.g. bypass or
angioplasty) as well as any previous minor amputations.
Time to death, in months, was calculated from the date
of the ﬁrst amputation. The last conﬁrmed date of contact
with medical care (hospital or general practitioner) was
recorded for censored data. People who had bilateral or re-
amputations were combined to one category, multiple
major amputation, with the underlying notion that these
cases had undergone multiple hospital admissions, anaes-
thesia and surgery, probably giving them a different
mortality risk than people with single amputations. This
categorisation procedure was chosen to enable sufﬁcient
numbers in each group for analyses.Statistical analysis
To consider differences in mortality for the different pop-
ulation characteristics, data were ﬁrst explored for a Cox
hazard model. However, the hazards were not proportional
over time, and thus assumptions for using this model were
not met. Instead, survival was analysed using Kaplan-Meier
curves and stratiﬁed Log Rank tests to check for differences
across independent and combined categories of sex, age,
level of amputation and diagnosis of diabetes. Missing data
were right censored at the last conﬁrmed contact date;
missing data were not imputed. Characteristics of the
population who died at 30-days, 1-year and 5-year were
compared to those who survived using c2 tests for cate-
gorical variables and t-test for age (normal distribution).
Variables with P < 0.1 were included in logistic regression
models (stepwise backward logistic regression) with 30-
day, 1-year and 5-year mortality (yes or no) as the
dependent variable. Discharge destination is presented for
descriptive purposes but not included in model due to
overlap with the category ‘death before discharge’. Statis-
tical signiﬁcance for analyses was 0.05 (two-sided). Anal-
yses were performed using Microsoft Excel 2003 and
SPSS 20.RESULTS
Population characteristics
Of 338 cases of LLA identiﬁed, 299 were due to a vascular,
infection and/or diabetes related cause and were included
for analysis (Table 1). The majority of cases were men (60%),
the mean age was 74.1 years and TTA was most frequent
Table 1. Characteristics of included population, with comparison of people with diabetes and people without diabetes.
Variable (n) Included
N ¼ 299
Diabetes
N ¼ 150
Non-diabetes
N ¼ 149
Pa
Level (298) n (%) n (%) n (%)
Transtibial 146 (49) 83 (56) 63 (42) .020
Knee disarticulation 27 (9) 12 (8) 15 (10)
Transfemoral 101 (34) 39 (26) 62 (42)
Bilateral 24 (8) 15 (10) 9 (6)
Sex (299)
Men 178 (60) 83 (55) 95 (64) .138
Women 121 (40) 67 (45) 54 (36)
Ageb (299) Mean (sd) Mean (sd) Mean (sd)
All 74.1 (11.2) 73.4 (10.5) 74.7 (11.8) .355
Men 72.1 (10.6) 71.1 (10.8) 72.9 (10.4) .266
Women 77.0 (11.5) 76.4 (9.5) 77.7 (13.6) .515
Admitted from (276) n (%) n (%) n (%)
Home 177 (64) 90 (65) 87 (64) .829
Care 99 (36) 49 (35) 50 (37)
Living situation (239)
Alone 139 (58) 79 (64) 60 (52) .050
Partner 100 (42) 44 (36) 56 (48)
Discharged to (294)
Home 42 (14) 24 (16) 18 (12) .371
Inpatient rehabilitation 40 (14) 19 (13) 21 (14)
Care 156 (53) 82 (55) 74 (51)
Died before discharge 56 (19) 23 (16) 33 (23)
Medical history (299)
Cardiac disease 114 (38) 57 (50) 57 (50) .964
Cerebrovascular disease 44 (15) 22 (15) 22 (15) 1.000
Chronic lung disease 66 (22) 30 (20) 36 (24) .403
Renal disease 59 (20) 39 (26) 20 (13) .006
Smoking (228)
Ever 137 (60) 56 (68) 81 (52) .016
Never 91 (40) 52 (33) 39 (48)
Surgical history (299)
Peripheral vascular procedure 150 (50) 68 (45) 82 (55) .093
1 minor amputation before major 46 (16) 48 (32) 14 (9) <.001
>1 major (either limb)c 68 (23) 36 (24) 32 (22) .351
Variable (n) ¼ number of valid observations for the stated variable; medical and surgical history were yes or not recorded so calculations
are based on whole population of 299.
a P is chi-square of people with diabetes compared to people without diabetes.
b Comparison of age by gender: with diabetes men versus women P ¼ 0.002; without diabetes men versus women P < 0.016.
c Includes amputations after study period.
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many living alone (58%). Discharge to care was most
common (53%), with 19% not surviving to be discharged
from the hospital.
Diabetes was diagnosed in 50% of the population. People
with diabetes had twice as many TTA (56%) than TFA (26%),
signiﬁcantly different to people without diabetes (TTA and
TFA both 42%; P ¼ .020). Renal disease was more prevalent
in people with diabetes (26%) than people without (13%,
P ¼ .005), with no differences seen between these groups
for other diagnoses. Previous minor amputations were
signiﬁcantly more likely for people with diabetes (32%) than
people without diabetes (9%, P < .001), whereas frequency
of vascular reconstructive procedures was somewhat less inpeople with diabetes (45% diabetes, 55% non-diabetes,
P ¼ 0.093).
Mortality
Mortality data were unable to be found for 30 (10%)
people. Fourteen could not be traced at all following their
discharge from hospital and 16 were not known by the
general practitioner listed in their ﬁle. These cases, with
unknown status, were older than people with a conﬁrmed
status (known ¼ 73.6 (11.0) years, unknown ¼ 78.0 (12.1)
years, P ¼ .044). There were no signiﬁcant differences in sex
(% men: known status ¼ 61%, unknown status ¼ 48%,
P ¼ .095) or level of amputation (known status: TTA ¼ 45%,
TFA ¼ 30%, unknown status: TTA ¼ 45%, TFA ¼ 38%).
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for 16 (5%) people.
The median time to death was 20.3 months (95% CI:
13.1; 27.5) (Table 2). For people with unilateral TTA, time to
death was longer at 27.8 months (22.0; 33.6), and for TFA
shorter at 10.6 months (1.2; 19.9) (median survival time by
level, P ¼ 0.495). Signiﬁcant differences between median
survival time were seen by age groups. People aged 85þ
years survived a median 8.8 months, while the remaining
younger age groups all survived 20þ months, (P ¼ .028).
Combining age and level, people with unilateral TFA aged
75e84 years had signiﬁcantly longer survival times (22.2
months) than younger (3.4 months) and older (2.1 months)
people with TFA. No differences were seen for people withTable 2. Cumulative percentage of people who died at 30-day, 1-year
level and diagnosis of diabetes.
Variable (n) Na n died % De
30-Day 1-Ye
All (283) 231 22 44
Level (279)
Unilateral transtibial 130 104 17 35
Unilateral transfemoral 83 69 27 54
Multiple major 66 57 23 45
Sex (283)
Men 167 141 22 43
Women 116 90 21 42
Age (283)
<65 years 59 39 19 38
65e74 years 77 64 24 45
75e84 years 103 87 15 38
85þ years 44 41 35 56
Diabetes (283)
No 140 111 22 45
Yes 143 120 20 41
Age and level (279)
Unilateral transtibial
<65 years 22 15 14 24
65e74 years 32 23 16 30
75e84 years 51 47 12 36
85þ years 25 19 34 45
Unilateral transfemoral
<65 years 13 10 31 62
65e74 years 26 23 32 64
75e84 years 31 21 14 35
85þ years 13 15 45 67
Multiple Major
<65 years 20 13 21 36
65e74 years 19 18 27 44
75e84 years 21 19 24 47
85þ years 6 7 17 67
Variable (n) ¼ number of valid observations for the stated variable.
a N is total number in category with conﬁrmed status, n died is number
missing data.
b P is log rank between categories for median survival time.or without diabetes (median (se) diabetes ¼ 25.0 (5.8)
months, non-diabetes ¼ 20.7 (5.0), P ¼ 0.969) (Fig. 1).
Twenty-two percent of the population died within 30-
days. Factors signiﬁcantly associated with 30-day mortality
were age, location admitted from, previous peripheral
vascular procedure and cerebrovascular disease (Table 3).
The odds of death within 30-days were 2.3 times greater for
those with cerebrovascular disease compared to those
without (95% CI: 1.17; 4.68, P ¼ .016) (Table 4).
After one year, 44% of the population had died. Variables
associated with mortality were age, location admitted from,
previous peripheral vascular procedure or previous minor
amputation and a diagnosis of cerebrovascular, renal or
cardiac disease. People with renal disease had 3.53 timesand 5-years, and median survival estimates (months) by age, sex,
ad Survival (months)
ar 5-Year Median se 95% CI Pb
77 20.3 3.7 (13.1; 27.5)
75 27.8 3.0 (22.0; 33.6) .495
77 10.6 4.8 (1.2; 19.9)
80 16.3 6.8 (2.9; 29.7)
76 21.1 4.1 (13.0; 29.1) .885
76 25.0 7.3 (10.8; 39.2)
65 26.7 9.9 (7.3; 46.0) .028
74 21.3 7.1 (7.5; 35.2)
81 25.0 4.1 (17.0; 33.1)
85 8.8 6.6 (0.0; 21.6)
75 20.7 5.0 (10.9; 30.5) .969
77 25.0 5.8 (13.6; 36.4)
60 30.8 10.1 (11.0; 50.5) .041
71 41.2 11.2 (19.2; 63.2)
82 26.6 2.7 (21.4; 31.9)
78 12.6 13.5 (0.0; 39.0)
77 8.2 4.9 (0.0; 17.9)
80 3.4 1.8 (0.0; 6.9)
70 22.2 21.7 (0.0; 64.7)
89 2.1 1.0 (0.0; 4.1)
68 37.9 21.4 (0.0; 79.9)
72 30.8 27.3 (0.0; 84.4)
94 12.8 10.5 (0.0; 33.4)
100 8.6 5.8 (0.0; 19.9)
with conﬁrmed death. Not all categories add to totals stated due to
Figure 1. Kaplan Meier survival estimates after a ﬁrst lower limb
amputation at or proximal to transtibial level, split for status of
diabetes. Based on information presented in Table 2, diabetes
n ¼ 143 total, 120 died; non-diabetes n ¼ 140 total 111 died.
Median (se) survival for people with diabetes ¼ 25.0 (5.8) months,
non-diabetes ¼ 20.7 (5.0), p ¼ 0.969.
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CI: 1.79; 6.96, P < .001) and cerebrovascular disease 2.5
times greater odds of dying than people without (95% CI:
1.21; 5.34, P ¼ .013). The ﬁve-year mortality rate was 77%,
with renal disease presenting 5.35 times greater odds of
dying (1.79; 16.0, P ¼ .003).DISCUSSION
Against a background of changing treatment options for
limb salvage, we aimed to review the effect this has on
mortality rates for the population who go on to have
a transtibial or proximal amputation. The mortality rates
reported in this study demonstrated the frailty of the
population, with 22% of people dying within 30-days. It has
been suggested that LLA in people with vascular disease
might be performed as pain relief at the end stages of care.6
Our results, with a high post-operative mortality, are in line
with that suggestion. Equivalent rates have been reported
in Scandinavian studies with 19e30% of people dying in the
ﬁrst month after LLA,1,6,7 while in other, comparable
western populations this is reported to be much lower,
around 10%.3,4,11e14 Investigation of underlying inﬂuences
from health services, surgical decisions and patient moti-
vations behind decisions to amputate might help to explain
some of the differences in post-operative mortality rates
between studies. As an example, a poorer mortality
outcome has been found when there are in-hospital delays
in decision making.15 Similarly, the health seeking behav-
iours of different populations should be explored for their
inﬂuence on time to presentation for treatment.For those who survive the post-operative period,
mortality outcomes were more consistent with other
studies. After 1 year, 44% of the population had died, falling
mid-range of results in literature at 30e50%.1,6,12,13,16 The
77% mortality rate at 5 years was higher than previous
ﬁndings of 56e70%.4,13,14 Direct comparisons of these
mortality outcomes are problematic owing to the differ-
ences in populations and reporting. However, the rates do
serve to highlight the variability in outcomes from reporting
different populations and emphasise a need to carefully
review the included population before applying results in
clinical, research or other contexts.
Diabetes remains the leading cause of major lower limb
amputation.17 The disease process differs from other
vascular-related causes and tends to result in transtibial or
distal amputation levels. With this, the inﬂuence of diabetes
on survival has been described as time-dependent, with
short term rates being the same or better than people
without diabetes but worse in the long term.2,3 Other
authors, including the current work, have found no differ-
ence in mortality rates for people with diabetes compared
to people without diabetes at any time point.6,18 These
conﬂicting ﬁndings between studies of diabetes and
mortality, may again arise from population differences, such
as inclusion of non-vascular amputations or people under-
going (partial) foot amputation.5 Outcomes should ideally
be reported separately for both the underlying cause and
level of amputation (in addition to diabetes status), to avoid
the bias resultant from non-vascular and mixed-level pop-
ulations. In the case of a ﬁrst amputation proximal to the
ankle, resulting from a vascular or infection related cause
only, there was no inﬂuence of diabetes diagnosis on
mortality rates.
Survival is generally described with negative wording,
such as ‘dismal.’13,19 Yet, considering the population as
frail and elderly, perhaps a more positive angle should
be stressed; almost one quarter of our cohort survived to 5
years. There should be a focus on ﬁnding determinants of
survivors to enable rehabilitation and long-term care
services for this group to be well planned. Speciﬁcally,
investigation of people who survived the post-operative
period but died within one ﬁrst year, in our case 22% of
the population, could lend support to rehabilitation
programs aimed at enhancing quality of life during this
short time. The most important inﬂuence on mortality at
30-days was the presence of cerebrovascular disease,
with renal disease having most inﬂuence after 1 and 5
years. Unfortunately, no other clear determinants of the
1-year survivors could be found but further investigation
of this group is suggested, as they are potentially an
important population from both surgical and rehabilitation
perspectives.
Complementary to investigating determinants of survival,
pre-operative care and the timing of amputation should be
looked at for its inﬂuence on differing mortality rates. Less
than 50% of our cohort received pre-amputation vascular
intervention. In the last decade, there have been increasing
possibilities for limb-salvage by means of both endovascular
Table 3. Characteristics of population who died at 30-days, 1-year and 5-years.
Variable (n) Total 30-Day death Pa 1 Year death Pa 5-Year death Pa
Level (266) n (%) n (%) n (%)
Unilateral transtibial 130 32 (25) .194 55 (42) .024 101 (78) .758
Unilateral proximal 70 30 (36) 51 (61) 67 (81)
Multiple major 66 20 (30) 33 (50) 54 (82)
Sex (283)
Men 167 47 (28) .599 81 (49) .594 131 (78) .725
Women 116 36 (31) 60 (52) 93 (80)
Ageb(283) Mean (sd) Mean (sd) Mean (sd) Mean (sd)
Died 74.1 (11.2) 75.8 (11.4) .043 75.3 (10.8) .015 75.0 (10.6) <.001
Alive 65.7 (12.9) 72.8 (11.1) 72.1 (11.5) 68.8 (12.2)
Admitted from (262) n (%) n (%) n (%)
Home 172 41 (24) .045 76 (44) .015 128 (74) .022
Care 90 32 (36) 54 (60) 78 (87)
Living situation (226)
Alone 94 24 (28) .677 44 (47) .981 75 (80) .399
Partner 132 37 (26) 62 (47) 99 (75)
Discharged to (278)
Home 41 6 (15) <.001 14 (34) .010 26 (63) <.001
Inpatient rehabilitation 37 1 (3) 6 (16) 20 (54)
Care 144 24 (17) 62 (43) 119 (83)
Died before discharge 56 50 (89) e e e
Medical history (299)
Diabetes 143 37 (26) .197 66 (46) .212 113 (79) .956
No 140 46 (33) 75 (54) 111 (79)
Cardiac disease 104 33 (32) .499 61 (59) .024 91 (88) .008
No 179 50 (28) 80 (45) 133 (74)
Cerebrovascular disease 42 19 (45) .014 28 (67) .018 36 (86) .257
No 241 64 (27) 113 (47) 188 (78)
Chronic lung disease 61 17 (28) .777 31 (51) .861 52 (85) .186
No 222 66 (30) 110 (50) 172 (78)
Renal disease 58 19 (33) .520 38 (66) .007 54 (93) .003
No 225 64 (28) 103 (46) 170 (76)
Smoking (218)
Ever 131 43 (33) .234 65 (50) .598 102 (78) .883
Never 87 22 (25) 40 (46) 67 (77)
Surgical history (299)
Peripheral vasc. procedure 141 35 (25) .097 63 (45) .085 110 (78) .639
None 142 48 (34) 78 (55) 114 (80)
1 minor amp before major 61 13 (21) .120 24 (39) .065 49 (80) .799
None 222 70 (32) 117 (53) 175 (79)
Variable (n) ¼ number of valid observations for the stated variable; medical and surgical history were yes or not recorded so calculations
are based on whole population of 299. Not all variables add up to 299 (population total) due to missing data.
a P is chi-square with survivors and non-survivors.
b t-test for age with survivors and non-survivors.
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these interventions may have on the population who go on
to have an amputation. Along this line, the timing of
amputation on both mortality and functional outcomes is
also of interest. This includes consideration of patients who
might beneﬁt from having an earlier amputation or fore-
going amputation entirely and choosing a palliative direc-
tion for care.20
A strength of this study design was the population-
based setting, which covered a wide geographic region.
Although the sample of people with amputation can beconsidered of a moderate size, some of the ﬁndings from
subgroup analyses may have been due to insufﬁcient
power to detect differences. Additionally, data were
retrieved directly from the medical ﬁles, giving insight to
information not available in our national database.21
However, a retrospective study presents inevitable limi-
tations, and also includes the problem of missing data.
Speciﬁcally, detailed information on the severity of
disease and cause of death were not reliably available but
would provide important additional information. Only co-
morbidities and items that were listed in the medical ﬁles
Table 4. Final logistic regression models for variables associated with 30-day, 1-year and 5-year death.
b (se) P OR 95% CI of OR
30-day death 1.20 (0.17)
Cerebrovascular disease 0.85 (0.35) .016 2.34 1.17; 4.68
Age (centered at 70 years) 0.02 (0.01) .070 1.02 1.00; 1.05
1-year death 0.43 (0.18)
Renal disease 1.26 (0.35) <.001 3.53 1.79; 6.96
Age (centered at 70 years) 0.04 (0.01) .002 1.04 1.02; 1.07
Cerebrovascular disease 0.93 (0.38) .013 2.55 1.21; 5.34
Minor amputation before major 0.70 (0.32) .030 0.50 0.27; 0.93
5-year death 0.79 (0.19)
Renal disease 1.68 (0.56) .003 5.35 1.79; 16.0
Age (centered at 70 years) 0.05 (0.01) <.001 1.05 1.02; 1.08
Admitted from care 0.62 (0.37) .099 1.90 0.89; 3.85
Final model ﬁt from backward stepwise LR presented.Nagelkerk R square 30-day ¼ .050; 1-year ¼ .143; 5 year ¼ .159.
ICD-code Description
Cardiac disease
410 Acute myocardial infarction
411 Other acute and subacute forms of ischemic
heart disease
398 Rheumatic heart disease
402 Hypertensive heart disease
428 Heart failure
History of Coronary Artery Bypass Graft
(CABG)a
Lung disease
491 Chronic obstructive pulmonary disease and
allied conditions
492 Emphysema
493 Asthma
Cerebrovascular disease
430 Subarachnoid hemorrhage
431 Intracerebral hemorrhage
432 Other and unspeciﬁed intracranial hemorrhage
433 Occlusion and stenosis of precerebral arteries
435 Transient cerebral ischemia
Renal disease
403 Hypertensive renal disease
404 Hypertensive heart and renal disease
580 Acute glomerulonephritis
581 Nephrotic syndrome
582 Chronic glomerulonephritis
583 Nephritis and nephropathy, not speciﬁed as
acute or chronic
584 Acute renal failure
585 Chronic renal failure
586 Renal failure, unspeciﬁed
Receiving dialysisa
Diabetes
250 Diabetes mellitus
Type I or Type IIa
ICD ¼ International Statistical Classiﬁcation of Diseases and
Related Health Problems.
a No coding, included as additional information to disease/
condition.
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underestimated the prevalence of some of these. An
important example is smoking, which was infrequently
recorded despite its known inﬂuence on post-amputation
healing and the need for revision surgeries.14 We could
not differentiate the cause beyond ‘vascular or infection
related’ although the underlying disease processes of
diagnoses differ, particularly with respect to chronic or
acute limb ischaemia. Cases that had undergone multiple
major amputations were combined to one group for
analyses, although the mortality risk may differ for people
with bilateral amputation compared to those who had
a re-amputation of the one limb. However, in our national
database, no differentiation between left- or right-sided
amputations can be made and future work will necessi-
tate this ‘multiple-major’ categorisation. Unfortunately,
10% of cases could not be traced following discharge from
the hospital and a further 5% had a conﬁrmed status but
no date of death could be traced. Although unknown
cases were older than conﬁrmed cases, we expect that
our estimates would not be largely affected, if anything
we may have slightly underestimated mortality rates.
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